Core Points - Nutex Health, Inc. is facing a class action lawsuit for investors who purchased securities between August 8, 2024, and August 14, 2025, with a deadline to file a lead plaintiff motion by October 21, 2025 [1] - Blue Orca Capital issued a short report on July 22, 2025, alleging that Nutex is exposed to litigation risk due to its association with HaloMD, which is involved in a fraudulent scheme against insurance companies [3] - Following the release of the Blue Orca report, Nutex's stock price dropped by $11.18 per share, or 10.05%, closing at $100.01 per share on the same day [3] Legal Representation - The Portnoy Law Firm is representing investors in claims related to corporate misconduct and offers complimentary case evaluations [2][4] - The founding partner of the Portnoy Law Firm has successfully recovered over $5.5 billion for investors in the past [4]
Portnoy Law Firm Announces Class Action on Behalf of Nutex Health, Inc. Investors